As of 2024-12-14, the Intrinsic Value of Yourgene Health PLC (YGEN.L) is
0.37 GBP. This YGEN.L valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 0.52 GBP, the upside of Yourgene Health PLC is
-27.50%.
The range of the Intrinsic Value is 0.21 - 2.11 GBP
YGEN.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(6.94) - (1.71) |
(2.53) |
-591.0% |
| DCF (Growth 10y) |
(1.58) - (5.26) |
(2.18) |
-522.3% |
| DCF (EBITDA 5y) |
0.21 - 2.11 |
0.37 |
-27.5% |
| DCF (EBITDA 10y) |
1.36 - 8.00 |
2.15 |
317.1% |
| Fair Value |
-1.28 - -1.28 |
-1.28 |
-348.50% |
| P/E |
(4.18) - (4.62) |
(4.76) |
-1024.4% |
| EV/EBITDA |
(0.17) - 0.27 |
(0.12) |
-122.5% |
| EPV |
(0.31) - (0.15) |
(0.23) |
-144.5% |
| DDM - Stable |
(3.03) - (14.97) |
(9.00) |
-1847.2% |
| DDM - Multi |
(0.05) - (0.19) |
(0.08) |
-115.2% |
YGEN.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
16.45 |
| Beta |
-3.69 |
| Outstanding shares (mil) |
31.93 |
| Enterprise Value (mil) |
31.98 |
| Market risk premium |
5.98% |
| Cost of Equity |
7.73% |
| Cost of Debt |
12.33% |
| WACC |
9.60% |